SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-04-000021
Filing Date
2004-08-13
Accepted
2004-08-13 15:39:19
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA 10Q 2ND QUARTER 2004 dor10q2ndquarter2004.htm 10QSB 254544
2 EXHIBIT 31.1 exhibit31w1.htm EX-31.1 10057
3 EXHIBIT 31.2 exhibit31w2.htm EX-31.2 9907
4 EXHIBIT 32.1 exhibit32w1.htm EX-32.1 5674
5 EXHIBIT 32.2 exhibit32w2.htm EX-32.2 5662
6 RISK FACTORS riskfactors.htm EX-99.1 CHARTER 43547
  Complete submission text file 0000812796-04-000021.txt   331701
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 04974179
SIC: 2834 Pharmaceutical Preparations